Ozanimod: all 37 studies that test it
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Ozanimod in Patients With Alzheimer's DiseaseRecruitingNCT06862960Phase 2
- Prospective Evaluation of Sequencing From antiCD-20 Therapies to OzanimodRecruitingNCT06529406Phase 4
- Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple SclerosisRecruitingNCT06408259Phase 3
- A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative ColitisRecruitingNCT05076175Phase 2/3
- A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional TherapyTerminatedNCT05470985Phase 2/3Results posted
- An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical PracticeTerminatedNCT05369832Phase 4Results posted
- An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's DiseaseTerminatedNCT03467958Phase 3Results posted
- A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's DiseaseTerminatedNCT03464097Phase 3Results posted
- Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's DiseaseCompletedNCT03440385Phase 3Results posted
- Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's DiseaseTerminatedNCT03440372Phase 3Results posted
- A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple SclerosisCompletedNCT02576717Phase 3Results posted
- An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative ColitisCompletedNCT02531126Phase 3Results posted
- Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's DiseaseCompletedNCT02531113Phase 2Results posted
- Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative ColitisCompletedNCT02435992Phase 3Results posted
- Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)CompletedNCT02294058Phase 3Results posted
- Efficacy and Safety Study of Ozanimod in Relapsing Multiple SclerosisCompletedNCT02047734Phase 3Results posted
- Efficacy and Safety Study of Ozanimod in Ulcerative ColitisCompletedNCT01647516Phase 2Results posted
- Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis PatientsCompletedNCT01628393Phase 2/3Results posted
- A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple SclerosisActive, not recruitingNCT06396039Phase 4
- Assessing the Cognitive Benefits of Ozanimod and Their Brain-Biomarkers in MSWithdrawnNCT06334094Phase 4
- Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ StudyWithdrawnNCT06188637Phase 4
- Multidimensional Integrated Assessment to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis.TerminatedNCT05777902Phase 4
- A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)TerminatedNCT05644665Phase 3
- Taste Assessment of OzanimodCompletedNCT05001152Phase 1
- Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult ParticipantsCompletedNCT04978298Phase 1
- A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of OzanimodCompletedNCT04639115Phase 1
- A Study to Evaluate the Relative Bioavailability of a Pediatric Granule Formulation of Ozanimod in Healthy Adult SubjectsCompletedNCT04528290Phase 1
- COVID-19 Ozanimod Intervention StudyTerminatedNCT04405102Phase 2
- A Study to Evaluate the Pharmacokinetics of Single Oral Doses of Ozanimod in Healthy Adult Chinese SubjectsCompletedNCT04211558Phase 1
- Drug Interaction Study of the Effect on Cyclosporine on Ozanimod and Major Active MetabolitesCompletedNCT04149678Phase 1
- Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)TerminatedNCT04140305Phase 3
- To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT03915769Phase 3
- Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor ResponseCompletedNCT03694119Phase 1
- Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Effect on Blood Pressure and Heart RateCompletedNCT03644576Phase 1
- Drug-drug Interaction Study of Ozanimod With Inhibitor or Inducer of CYP2C8 and/or CYP3ACompletedNCT03624959Phase 1
- A Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male AdultsCompletedNCT02994381Phase 1
- Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMSCompletedNCT02797015Phase 1